Post job

Eureka Therapeutics executives

Work at Eureka Therapeutics?
Share your experience

Rate Eureka Therapeutics' leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Cheng Liu

Board Member

Cheng Liu's LinkedIn

Cheng Liu is the founder and CEO of Eureka Therapeutics, a California biotech company dedicated to antibody research and discovery for cancer immunotherapy. Prior to founding Eureka, Dr. Liu was a Principal Scientist in antibody drug discovery at Chiron (now Novartis), where he championed anti-CSF1 antibody program for treatment of bone metastasis to human clinical trials. He is the inventor of multiple issued US patents in drug discovery. In 2007, he was awarded Special US Congressional Recognition for his contributions to improving human health. Dr. Liu received his B.S. in Cell Biology and Genetics from Beijing University and a Ph.D. in Molecular Cell Biology from the University of California, Berkeley.

Vivien Chan

COO, Executive

Vivien Chan's LinkedIn

Worked at Eureka Therapeutics. Lives in Emeryville, CA. Attended University of California, San Francisco.

Cheng Kai

Board Member

Hanzhong Li

Senior Vice President of Corporate Strategy

Hsing Kung

Board Member

Victor Shum

General Counsel & Chief Business Officer

Wei Chu

Board Member

Do you work at Eureka Therapeutics?

Does leadership effectively guide Eureka Therapeutics toward its goals?

Eureka Therapeutics jobs

Eureka Therapeutics founders

Name & TitleBio
Cheng Liu

Board Member

Cheng Liu's LinkedIn

Cheng Liu is the founder and CEO of Eureka Therapeutics, a California biotech company dedicated to antibody research and discovery for cancer immunotherapy. Prior to founding Eureka, Dr. Liu was a Principal Scientist in antibody drug discovery at Chiron (now Novartis), where he championed anti-CSF1 antibody program for treatment of bone metastasis to human clinical trials. He is the inventor of multiple issued US patents in drug discovery. In 2007, he was awarded Special US Congressional Recognition for his contributions to improving human health. Dr. Liu received his B.S. in Cell Biology and Genetics from Beijing University and a Ph.D. in Molecular Cell Biology from the University of California, Berkeley.

Eureka Therapeutics board members

Name & TitleBio
Cheng Liu

Board Member

Cheng Liu's LinkedIn

Cheng Liu is the founder and CEO of Eureka Therapeutics, a California biotech company dedicated to antibody research and discovery for cancer immunotherapy. Prior to founding Eureka, Dr. Liu was a Principal Scientist in antibody drug discovery at Chiron (now Novartis), where he championed anti-CSF1 antibody program for treatment of bone metastasis to human clinical trials. He is the inventor of multiple issued US patents in drug discovery. In 2007, he was awarded Special US Congressional Recognition for his contributions to improving human health. Dr. Liu received his B.S. in Cell Biology and Genetics from Beijing University and a Ph.D. in Molecular Cell Biology from the University of California, Berkeley.

Cheng Kai

Board Member

Hsing Kung

Board Member

Wei Chu

Board Member

Eureka Therapeutics executives FAQs

Zippia gives an in-depth look into the details of Eureka Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Eureka Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Eureka Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Eureka Therapeutics. The data presented on this page does not represent the view of Eureka Therapeutics and its employees or that of Zippia.

Eureka Therapeutics may also be known as or be related to Eureka Therapeutics, Eureka Therapeutics Inc, Eureka Therapeutics, Inc and Eureka Therapeutics, Inc.